If there is high upfront training cost (filtering, classifying data, etc) then what we may find is a situation similar to drug pricing where the cost of the end product remains high and the motivation to keep it closed is there to justify the research input. Any similarity to the pharma industry doesn't inspire confidence in cheapness and openness.